{"id":"W4416586053","doi":"10.1016/j.jid.2025.10.101","title":"097 Phase 3 results from an innovative trial design of treating plaque psoriasis involving difficult-to-treat, high-impact sites with icotrokinra, a targeted oral peptide that selectively inhibits the IL-23–receptor","year":2025,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Lynde Centre for Dermatology; Probity Medical Research; Innovaderm (Canada); SKiN Health","funders":"","keywords":"Plaque psoriasis; Scalp; Psoriasis; Peptide; Open label; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00243824,0.001401468,0.00152812,0.0003515165,0.0004577881,0.00132666,0.0007215817,0.001845233,0.008129837],"category_scores_gemma":[0.001258336,0.0005094169,0.001888429,0.0003122494,0.0009188828,0.0007077566,0.0003307772,0.003325453,0.001432113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000689044,"about_ca_system_score_gemma":0.001434263,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008978688,"about_ca_topic_score_gemma":0.002254773,"domain_scores_codex":[0.9993962,0.0002852833,0.0000250038,0.0001038682,0.00005452236,0.0001350961],"domain_scores_gemma":[0.9992868,0.0002184163,0.0001100518,0.00007182033,0.00005557891,0.000257265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8662341,0.03012471,0.001398839,0.0007870672,0.002168609,0.0001770474,0.0001444561,0.002498021,0.0271866,0.0009488027,0.007962059,0.06036961],"study_design_scores_gemma":[0.8382523,0.1531631,0.001758545,0.00003639255,0.000563607,0.00009896787,0.00002656586,0.0008271725,0.001569475,0.0004658487,0.003208809,0.00002933559],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9682792,0.004262968,0.003951032,0.002479462,0.00113862,0.007461271,0.004306484,0.0002747166,0.007846262],"genre_scores_gemma":[0.9529098,0.002840887,0.01145611,0.00466082,0.0006938111,0.01102395,0.004752117,0.0001514236,0.01151114],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008129837,"threshold_uncertainty_score":0.027197,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03614814502020658,"score_gpt":0.2895866066337019,"score_spread":0.2534384616134954,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}